Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00659035Active Not Recruiting

Use of Driving Tests to Evaluate Patient Performance on Oral Opioids

Role: lead

NCT00729092Completed

Additional Positron Emission Tomography (PET) Scan of Brain in Patients Undergoing PET Scan for Diseases Unrelated to Brain

Role: lead

NCT00729690Phase 3Completed

Effect of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Knee Replacement

Role: lead

All 3 trials loaded